Atlas Trials

Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma

Clinical trial NCT01687673 · COMPLETED

Trial details

NCT number
NCT01687673
Sponsor
University of California, San Francisco
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2012-10-05
Primary completion
2016-04-26
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.